Northern Trust’s Pharvaris PHVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.36M Buy
83,468
+2,433
+3% +$65K ﹤0.01% 2881
2025
Q4
$2.25M Buy
81,035
+3,080
+4% +$74.2K ﹤0.01% 2931
2025
Q3
$1.94M Sell
77,955
-17,314
-18% -$384K ﹤0.01% 3051
2025
Q2
$1.68M Buy
95,269
+8,393
+10% +$135K ﹤0.01% 3092
2025
Q1
$1.36M Sell
86,876
-5,056
-5% -$85.3K ﹤0.01% 3129
2024
Q4
$1.76M Buy
91,932
+76,188
+484% +$1.57M ﹤0.01% 3098
2024
Q3
$292K Buy
+15,744
New +$288K ﹤0.01% 3752

Other funds holding PHVS

Northern Trust's PHVS Position: Q1 2026 in Review

Northern Trust increased its Pharvaris (PHVS) stake by 3% in Q1 2026, buying an estimated $65K and bringing the position to 83,468 shares worth $2.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2881.

Northern Trust first reported a position in PHVS in Q3 2024 and has held it in 7 quarters since. 110 funds tracked by Wall St. Rank hold PHVS as of Q1 2026.

  • Northern Trust held 83,468 shares of Pharvaris worth $2.36M as of Q1 2026.
  • Northern Trust bought 2,433 Pharvaris shares in Q1 2026, an estimated $65K.
  • Pharvaris made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2881 holding.
  • Northern Trust first reported a position in Pharvaris in Q3 2024 and has held it in 7 quarters since.
  • 110 funds tracked by Wall St. Rank held Pharvaris as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.